Tauriga Sciences Inc (TAUG) Financial Statements (2024 and earlier)

Company Profile

Business Address 4 NANCY COURT, SUITE 4
WAPPINGERS FALLS, NY 12590
State of Incorp. FL
Fiscal Year End March 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments53861211213
Cash and cash equivalents5386120 209
Short-term investments    114
Receivables(22) 1   
Inventory, net of allowances, customer advances and progress billings12911   91
Inventory12911   91
Disposal group, including discontinued operation  1    
Other undisclosed current assets4955506732329
Total current assets:60894868633333
Noncurrent Assets
Operating lease, right-of-use asset22
Property, plant and equipment131321725
Intangible assets, net (including goodwill)      (1,456)
Intangible assets, net (excluding goodwill)      (1,456)
Other undisclosed noncurrent assets     1,456
Total noncurrent assets:361321725
TOTAL ASSETS:643961689410359
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16265641,246603558
Interest and dividends payable3931341268714
Accounts payable763530279307272
Accrued liabilities47  841209271
Deferred revenue 0
Debt63521425530625549
Deferred compensation liability    190306496
Derivative instruments and hedges, liabilities    72367190
Disposal group, including discontinued operation  6    
Customer refund liability00    
Due to related parties     18 
Other undisclosed current liabilities145172  453486
Total current liabilities:9434573192,4652,3051,679
Noncurrent Liabilities
Long-term debt and lease obligation:9     
Liabilities, other than long-term debt    75  
Other liabilities    75  
Operating lease, liability9
Other undisclosed noncurrent liabilities(9) 75   
Total noncurrent liabilities:9 7575  
Total liabilities:9524573942,5402,3051,679
Equity
Equity, attributable to parent(308)503297(2,537)(2,295)(1,320)
Common stock113917129
Additional paid in capital58,21355,99254,64251,77149,74648,151
Accumulated other comprehensive income (loss)   8(240)(240)(236)
Accumulated deficit(58,523)(55,489)(54,392)(54,084)(51,813)(49,244)
Equity, attributable to noncontrolling interest   (2)   
Total equity:(308)503295(2,537)(2,295)(1,320)
TOTAL LIABILITIES AND EQUITY:643961689410359

Income Statement (P&L) ($ in thousands)

3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenues234571  96
Revenue, net   96
Other income  100   
Cost of revenue(197)(37)(1) (324)(42)
Cost of goods and services sold  (17)  (42)
Financial services costs  (324) 
Gross profit:37200 (324)54
Operating expenses(2,076)(1,103)(1,973)(1,549)(2,037)(4,169)
Other undisclosed operating income     324 
Operating loss:(2,039)(1,083)(1,973)(1,549)(2,037)(4,114)
Nonoperating income (expense)(994)(12)1,898(723)(436)(975)
Investment income, nonoperating    (86)(153) 
Interest and debt expense113(138)(292)(25)(321)(187)
Loss from continuing operations before equity method investments, income taxes:(2,920)(1,233)(366)(2,297)(2,794)(5,276)
Other undisclosed income (loss) from continuing operations before income taxes(113)138    
Loss from continuing operations before income taxes:(3,033)(1,095)(366)(2,297)(2,794)(5,276)
Other undisclosed income from continuing operations    25321 
Loss from continuing operations:(3,033)(1,095)(366)(2,271)(2,473)(5,276)
Loss before gain (loss) on sale of properties:(3,033)(1,097)(366)(2,271)(2,569)(5,276)
Loss from discontinued operations  (2)  (96) 
Other undisclosed net income   292   
Net loss:(3,033)(1,097)(75)(2,271)(2,569)(5,276)
Net loss attributable to noncontrolling interest   (39)   
Other undisclosed net income attributable to parent   77  187
Net loss attributable to parent:(3,033)(1,097)(36)(2,271)(2,569)(5,089)
Preferred stock dividends and other adjustments   (271)   
Net loss available to common stockholders, diluted:(3,033)(1,097)(307)(2,271)(2,569)(5,089)

Comprehensive Income ($ in thousands)

3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net loss:(3,033)(1,097)(75)(2,271)(2,569)(5,276)
Other comprehensive income (loss)   323(0)(4)(55)
Comprehensive income (loss):(3,033)(1,097)248(2,271)(2,573)(5,331)
Comprehensive loss, net of tax, attributable to noncontrolling interest   (39)   
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (285)  187
Comprehensive loss, net of tax, attributable to parent:(3,033)(1,097)(75)(2,271)(2,573)(5,144)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: